Johnson & Johnson [NYSE: JNJ] traded at a low on Monday, posting a -2.18 loss after which it closed the day’ session at $151.27.
The results of the trading session contributed to over 7729170 shares changing hands. Over the past one week, the price volatility of Johnson & Johnson stands at 1.12% while the volatility over the past one month is 1.36%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for JNJ stock reached $364.06 billion, with 2.41 billion shares outstanding and 2.40 billion shares in the current float. Compared to the average trading volume of 7.46M shares, JNJ reached a trading volume of 7729170 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Johnson & Johnson [JNJ]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $172.65 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
HSBC Securities have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 18, 2024. While these analysts kept the previous recommendation, Wells Fargo dropped their target price from $170 to $163. The new note on the price target was released on December 13, 2023, representing the official price target for Johnson & Johnson stock. Previously, the target price had yet another raise from $167 to $180, while UBS kept a Buy rating on JNJ stock.
The Average True Range (ATR) for Johnson & Johnson is set at 2.15, with the Price to Sales ratio for JNJ stock in the period of the last 12 months amounting to 4.06. The Price to Book ratio for the last quarter was 5.20, with the Price to Cash per share for the same quarter was set at 10.89. Price to Free Cash Flow for JNJ in the course of the last twelve months was 19.46 with Quick ratio for the last quarter at 0.94.
How has JNJ stock performed recently?
Johnson & Johnson [JNJ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.03. With this latest performance, JNJ shares gained by 2.27% in over the last four-week period, additionally plugging by 0.78% over the last 6 months – not to mention a drop of -4.55% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JNJ stock in for the last two-week period is set at 51.31, with the RSI for the last a single of trading hit 51.84, and the three-weeks RSI is set at 49.75 for Johnson & Johnson [JNJ]. The present Moving Average for the last 50 days of trading for this stock 152.16, while it was recorded at 152.85 for the last single week of trading, and 156.83 for the last 200 days.
Johnson & Johnson [JNJ]: Deeper insight into the fundamentals
Johnson & Johnson’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.94 and a Current Ratio set at 1.17.
Earnings analysis for Johnson & Johnson [JNJ]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 5.23%.
Insider trade positions for Johnson & Johnson [JNJ]
The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in JNJ stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in JNJ stock with ownership which is approximately 5.8386%.
